# Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis

> **NCT05802056** · PHASE1 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 15 (estimated)

## Conditions studied

- Clinical Stage IV Gastric Cancer AJCC v8
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Metastatic Gastric Carcinoma
- Metastatic Malignant Neoplasm in the Peritoneum

## Interventions

- **BIOLOGICAL:** Aldesleukin
- **PROCEDURE:** Biopsy
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Diagnostic Laparoscopy
- **DRUG:** Fluorouracil
- **DRUG:** Leucovorin Calcium
- **PROCEDURE:** Magnetic Resonance Imaging
- **BIOLOGICAL:** Nivolumab
- **DRUG:** Oxaliplatin
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT05802056
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-29
- **Primary completion:** 2027-04-15
- **Final completion:** 2030-04-15
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05802056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05802056, "Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05802056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*